Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging.
about
You're only as old as your arteries: translational strategies for preserving vascular endothelial function with agingWhy are sex and gender important to basic physiology and translational and individualized medicine?Rapamycin extends murine lifespan but has limited effects on aging.Cryptosporidium parvum-induced ileo-caecal adenocarcinoma and Wnt signaling in a mouse model.From rapalogs to anti-aging formula.In search of antiaging modalities: evaluation of mTOR- and ROS/DNA damage-signaling by cytometry.Aspirin resistance with genetic dyslipidemia: contribution of vascular thromboxane generation.Improvement of aging-associated cardiovascular dysfunction by the orally administered copper(II)-aspirinate complexLow-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis from the JPAD trialHistone deacetylase 3 antagonizes aspirin-stimulated endothelial nitric oxide production by reversing aspirin-induced lysine acetylation of endothelial nitric oxide synthase.Cryptosporidium parvum infection in SCID mice infected with only one oocyst: qPCR assessment of parasite replication in tissues and development of digestive cancer.Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signalingProtective role of acetylsalicylic acid in experimental Trypanosoma cruzi infection: evidence of a 15-epi-lipoxin A₄-mediated effect.Old age as a privilege of the "selfish ones".Fulminant cryptosporidiosis after near-drowning: a human Cryptosporidium parvum strain implicated in invasive gastrointestinal adenocarcinoma and cholangiocarcinoma in an experimental modelKoschei the immortal and anti-aging drugsAntiinflammatory treatment ameliorates HPA stress axis dysfunction in a mouse model of stress sensitivityPositive influence of aspirin on coronary endothelial function: Importance of the dose.Thymus and aging: morphological, radiological, and functional overview.Dysfunction of endothelial and smooth muscle cells in small arteries of a mouse model of Marfan syndrome.Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.Endothelial dysfunction and vascular disease - a 30th anniversary update.Non-steroidal anti-inflammatory drugs attenuate the vascular responses in aging metabolic syndrome rats.Protection of vascular endothelium by aspirin in a murine model of chronic Chagas' disease.Regulation on RhoA in vascular smooth muscle cells under inflammatory stimulation proposes a novel mechanism mediating the multiple-beneficial action of acetylsalicylic acid.Epigenetic alterations in longevity regulators, reduced life span, and exacerbated aging-related pathology in old father offspring mice.Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice.Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.
P2860
Q26824357-CD9A18CC-689F-4682-AE99-29DFCE80B2D0Q27022386-6ED07D1A-732B-432B-9D02-0A67DDC216DAQ30541884-7600DAB7-4C56-4DF7-95EE-FA6175CDFB67Q33677234-E3CF667B-25B8-437B-9C9D-6855699F2EBDQ33829205-25CF8196-2221-41DC-B8B1-DEB176B4DA52Q33841800-C4D64711-905E-4377-B29A-2882EE3D0D3BQ34090742-0C05E86C-9284-4C7B-841C-2AD3D3D90BBAQ34307113-8E3D94D4-8C58-4ECE-9CD1-A3E20891CDFAQ34507032-5A9A0643-B1E3-452D-B238-F11D1704619DQ34514079-534F2160-7057-432F-A279-AF928320412FQ34525197-B7862E52-F8B4-47E4-B2AD-D7F7DB614857Q34567724-BA6CCDC4-164E-4E05-AD43-C0D72C87DB95Q34702419-5F0F49A1-142C-4138-BFA0-EC09446B425FQ35806701-C728717E-14E1-47AF-8EEB-6C6FBF7B2509Q35816959-528FFE52-3B11-49A7-9BD5-7267BA32BD73Q36292001-C11F99ED-CAD1-49CE-B28E-57EE6EEB8231Q36439429-831C2D60-9CB0-446D-99F3-11D4E5D328A2Q37378488-C9AE2707-3A24-4BE6-A0E3-ACC73E2FF906Q37471102-D413CA5F-3101-4993-B19F-DEF2A267F57EQ37481240-5B2F7478-6D63-4383-8871-032990223BD6Q37971308-BD57DCCA-4B33-4E42-AC38-BA67A8DF615EQ38680112-43C94849-F2D0-4529-A6F9-0418226244FAQ42263009-5F40D312-7312-4280-8DE1-04BFA4B7192CQ44082471-0AF85B66-8135-4D7C-BC67-29240A16EDE8Q46815366-20426235-703D-4E9E-9BF7-DDDE12294FD7Q51768178-275B6D17-0A78-418B-8D5E-017FDE77A445Q52657200-96CF6DF8-257E-4FCB-9DED-0A59380BEA9FQ52887626-0FBC574B-57AB-437A-9A01-84F5C3803FB5
P2860
Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Low-dose aspirin prevents age- ...... model of physiological aging.
@en
Low-dose aspirin prevents age- ...... model of physiological aging.
@nl
type
label
Low-dose aspirin prevents age- ...... model of physiological aging.
@en
Low-dose aspirin prevents age- ...... model of physiological aging.
@nl
prefLabel
Low-dose aspirin prevents age- ...... model of physiological aging.
@en
Low-dose aspirin prevents age- ...... model of physiological aging.
@nl
P2093
P2860
P1476
Low-dose aspirin prevents age- ...... e model of physiological aging
@en
P2093
Bruno Corman
Colette Creusy
Cédric Gaxatte
François Puisieux
Gaétan Prévost
Guillaume Garçon
Géraldine Robitaille
Hélène Bulckaen
Pierre Gosset
Pirouz Shirali
P2860
P304
P356
10.1152/AJPHEART.00241.2007
P577
2008-01-25T00:00:00Z